Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is not the active ingredient in any FDA-approved drug product, and there is no United States Pharmacopeia (USP) monograph for either AOD-9604 (free base) or AOD-9604 acetate
Note: 5-Amino-1MQ is a quinolinium compound, not a peptide
The peer-reviewed literature is also concentrated within a single research group (Watowich lab, University of Texas at Austin) and its industry partner Ridgeline Therapeutics, with limited independent replication to date
NOT FOR HUMAN USE, DRUG, HOUSEHOLD, OR COSMETIC APPLICATIONS
There have been postmarketing reports of renal impairment, acute kidney injury, and worsening of chronic renal failure, which sometimes has required hemodialysis, in patients treated with GLP-1 receptor agonists
Additional support For details about your medication and dosing, please log in to your patient portal
US$ 24.63
US$ 22.72
US$ 25.19
